DE60015560D1 - Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz - Google Patents

Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz

Info

Publication number
DE60015560D1
DE60015560D1 DE60015560T DE60015560T DE60015560D1 DE 60015560 D1 DE60015560 D1 DE 60015560D1 DE 60015560 T DE60015560 T DE 60015560T DE 60015560 T DE60015560 T DE 60015560T DE 60015560 D1 DE60015560 D1 DE 60015560D1
Authority
DE
Germany
Prior art keywords
treatment
amino acid
insulin resistance
production
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60015560T
Other languages
English (en)
Other versions
DE60015560T2 (de
Inventor
Gerard Ribes
Mohammed Taouis
Roger Petit
Christophe Broca
Yves Sauvaire
Bernard Pau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innodia Inc
Original Assignee
Innodia SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innodia SAS filed Critical Innodia SAS
Application granted granted Critical
Publication of DE60015560D1 publication Critical patent/DE60015560D1/de
Publication of DE60015560T2 publication Critical patent/DE60015560T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60015560T 1999-08-27 2000-08-23 Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz Expired - Fee Related DE60015560T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9910874A FR2797767B1 (fr) 1999-08-27 1999-08-27 Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
FR9910874 1999-08-27
PCT/FR2000/002361 WO2001015689A1 (fr) 1999-08-27 2000-08-23 Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances

Publications (2)

Publication Number Publication Date
DE60015560D1 true DE60015560D1 (de) 2004-12-09
DE60015560T2 DE60015560T2 (de) 2005-12-15

Family

ID=9549397

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60015560T Expired - Fee Related DE60015560T2 (de) 1999-08-27 2000-08-23 Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz

Country Status (15)

Country Link
US (2) US7402611B1 (de)
EP (2) EP1421937A1 (de)
JP (1) JP2003508435A (de)
CN (1) CN1208055C (de)
AT (1) ATE281159T1 (de)
AU (1) AU7015700A (de)
CA (1) CA2382835A1 (de)
DE (1) DE60015560T2 (de)
DK (1) DK1206257T3 (de)
ES (1) ES2231247T3 (de)
FR (1) FR2797767B1 (de)
HK (1) HK1052456A1 (de)
PT (1) PT1206257E (de)
WO (1) WO2001015689A1 (de)
ZA (1) ZA200201619B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338675B2 (en) * 2002-05-10 2008-03-04 Tsi Health Sciences, Inc. Fenugreek seed bio-active compositions and methods for extracting same
FR2847897B1 (fr) * 2002-12-02 2006-02-24 Centre Nat Rech Scient Procede de preparation de diasteroisomeres et d'enantiomeres de la 4-hydroxyisoleucine et de ses derives
KR20050110018A (ko) 2003-03-19 2005-11-22 교와 핫꼬 고교 가부시끼가이샤 당뇨병 치료제
FR2856297B1 (fr) * 2003-06-18 2005-08-05 Caster Utilisation de (2s,3r,4s)-4-hydroxyisoleucine dans des compositions cosmetiques pour application topique
WO2005039626A2 (en) * 2003-10-27 2005-05-06 Innodia Inc. Use of hydroxylated amino acids for treating diabetes
US7645466B2 (en) 2004-03-02 2010-01-12 Tsi Group Limited Methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seed
US20060057228A1 (en) * 2004-07-09 2006-03-16 Pure World Botanicals, Inc. Weight loss composition
BRPI0607140A2 (pt) * 2005-02-18 2009-08-11 Innodia Inc composto, uso do composto e/ou uso de um sal, lactona ou pró-medicamento farmaceuticamente aceitável do dito composto, composição farmacêutica, kit farmacêutico, método para estimular a captação de glicose pelas células musculares e/ou células de adipócito, método para estimular a secreção de insulina pelas células pancreáticas células-(beta) e método para o tratamento de um mamìfero que tem um distúrbio do metabolismo de carboidratos ou de lipìdios
WO2006131836A2 (en) * 2005-03-22 2006-12-14 Innodia Inc. Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
WO2007107008A1 (en) * 2006-03-22 2007-09-27 Innodia Inc. Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
US20100124583A1 (en) * 2008-04-30 2010-05-20 Xyleco, Inc. Processing biomass
JPWO2008102671A1 (ja) 2007-02-22 2010-05-27 味の素株式会社 ４−ヒドロキシイソロイシンの精製方法
SI2276795T1 (sl) 2008-04-30 2015-09-30 Xyleco, Inc. Obdelava biomase
CN108078973A (zh) * 2017-12-25 2018-05-29 郑州大学 4-羟基异亮氨酸的新用途
CN112089710B (zh) * 2020-08-07 2022-04-01 郑州大学 4-羟基异亮氨酸在制备抗肿瘤药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
US5591709A (en) 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
FR2695317B1 (fr) * 1992-09-07 1995-03-10 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
IL108583A (en) 1994-02-07 1997-06-10 Yissum Res Dev Co Galactomannan emulsions and comestible products containing the same
GB9517443D0 (en) * 1994-12-17 1995-10-25 Univ Nottingham Increasing creatine and glycogen concentration in muscle
FR2745718B1 (fr) * 1996-03-08 1998-05-07 Gestion Jouvenet Soc Civ De Composition antidiabetique a base de 4-hydroxyisoleucine
WO1998021592A1 (en) * 1996-11-13 1998-05-22 Receptron Corporation Assays for non-insulin dependent diabetes
ES2242995T3 (es) 1997-01-15 2005-11-16 Telik, Inc. Moduladores de la actividad del receptor de la insulina.
CA2206157C (en) 1997-05-26 2000-06-13 Cheng, Peter Method of extraction of commercially valuable fractions of fenugreek

Also Published As

Publication number Publication date
CN1208055C (zh) 2005-06-29
EP1206257A1 (de) 2002-05-22
US20080287344A1 (en) 2008-11-20
CN1376062A (zh) 2002-10-23
DK1206257T3 (da) 2005-03-14
FR2797767A1 (fr) 2001-03-02
DE60015560T2 (de) 2005-12-15
WO2001015689A1 (fr) 2001-03-08
US7402611B1 (en) 2008-07-22
ATE281159T1 (de) 2004-11-15
HK1052456A1 (en) 2003-09-19
ZA200201619B (en) 2003-07-30
ES2231247T3 (es) 2005-05-16
EP1421937A1 (de) 2004-05-26
JP2003508435A (ja) 2003-03-04
PT1206257E (pt) 2005-03-31
CA2382835A1 (fr) 2001-03-08
AU7015700A (en) 2001-03-26
FR2797767B1 (fr) 2002-06-14
EP1206257B1 (de) 2004-11-03

Similar Documents

Publication Publication Date Title
ATE281159T1 (de) Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz
DE60103453D1 (de) Verwendung von albuminstabilisiertem Paclitaxel zur Herstellung eines Arzneimittels zum Behandeln von festen Tumoren und das so erhaltene Arzneimittel
DE60004974D1 (de) Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen
DE69811371D1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung
ATE396198T1 (de) 17alpha-alkyl-17beta-oxy-estratriene und zwischenprodukte zu deren herstellung, verwendung der 17alpha-alkyl-17beta-oxy-estratriene zur herstellung von arzneimitteln sowie pharmazeutische präparate
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
FI952060A (fi) Menetelmä atsitromysiinin annostamiseksi
DE602004026701D1 (de) Implantierbares medizinprodukt zur selektiven modulation der abgabe von mitteln in situ
WO2003030927A3 (fr) Utilisation de peptides analogues de la thymuline (pat) pour la fabrication de medicaments contre la douleur
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
ATE274916T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE59101776D1 (de) Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen.
ATE311866T1 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur
DE69716223D1 (de) Vorrichtung zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung
ATE94764T1 (de) Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung.
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE60322871D1 (de) Thaltende zubereitungen
ATE252903T1 (de) Arzneimittel zur behandlung konvulsivischer zustände
ATE454897T1 (de) Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation
DE60122781D1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
DE60336596D1 (de) Ortspezifische verabreichung von aktiven substanzen im darm
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
CA2405265A1 (en) Method of preventing or treating diabetes

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: INNODIA INC., MONTREAL, QUEBEC, CA

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOCKHORNI & KOLLEGEN, 80687 MUENCHEN

8339 Ceased/non-payment of the annual fee